Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(2.86)
# 1,278
Out of 4,424 analysts
24
Total ratings
34.78%
Success rate
3.2%
Average return
Main Sectors:
Top Industries:
11 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Reiterates: Overweight | $65 | $35.82 | +81.46% | 3 | May 3, 2024 | |
| ORIC ORIC Pharmaceuticals | Initiates: Overweight | n/a | $8.99 | - | 1 | Feb 23, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Neutral | n/a | $4.33 | - | 2 | Feb 20, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Overweight | $78 | $40.92 | +90.62% | 8 | Nov 8, 2023 | |
| AKRO Akero Therapeutics | Maintains: Overweight | $69 → $39 | $19.65 | +98.47% | 3 | Oct 11, 2023 | |
| TGTX TG Therapeutics | Reiterates: Overweight | $24 | $16.62 | +44.40% | 2 | Apr 17, 2023 | |
| TCRT Alaunos Therapeutics | Assumes: Overweight | $45 | $1.24 | +3,529.03% | 1 | Jul 15, 2022 | |
| LABP Landos Biopharma | Initiates: Buy | n/a | $22.33 | - | 1 | Sep 23, 2021 | |
| LIFE aTyr Pharma | Initiates: Buy | n/a | $1.69 | - | 1 | May 18, 2021 | |
| OCUP Ocuphire Pharma | Initiates: Buy | n/a | $1.72 | - | 1 | Mar 29, 2021 | |
| EQ Equillium | Initiates: Buy | n/a | $1.53 | - | 1 | Mar 3, 2021 |
Structure Therapeutics
May 3, 2024
Reiterates: Overweight
Price Target: $65
Current: $35.82
Upside: +81.46%
ORIC Pharmaceuticals
Feb 23, 2024
Initiates: Overweight
Price Target: n/a
Current: $8.99
Upside: -
RAPT Therapeutics
Feb 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.33
Upside: -
MoonLake Immunotherapeutics
Nov 8, 2023
Reiterates: Overweight
Price Target: $78
Current: $40.92
Upside: +90.62%
Akero Therapeutics
Oct 11, 2023
Maintains: Overweight
Price Target: $69 → $39
Current: $19.65
Upside: +98.47%
TG Therapeutics
Apr 17, 2023
Reiterates: Overweight
Price Target: $24
Current: $16.62
Upside: +44.40%
Alaunos Therapeutics
Jul 15, 2022
Assumes: Overweight
Price Target: $45
Current: $1.24
Upside: +3,529.03%
Landos Biopharma
Sep 23, 2021
Initiates: Buy
Price Target: n/a
Current: $22.33
Upside: -
aTyr Pharma
May 18, 2021
Initiates: Buy
Price Target: n/a
Current: $1.69
Upside: -
Ocuphire Pharma
Mar 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.72
Upside: -
Equillium
Mar 3, 2021
Initiates: Buy
Price Target: n/a
Current: $1.53
Upside: -